Evidence map›Paper›PMID 28223357›Full record

ArticleThe Journal of biological chemistry2017

Lipid sensing by mTOR complexes via

Deepak Menon, Darin Salloum, Elyssa Bernfeld, Elizabeth Gorodetsky, Alla Akselrod, Maria A Frias, Jessica Sudderth, Pei-Hsuan Chen, Ralph DeBerardinis, David A Foster

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 120 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Fast fragmenting mitochondria by TORC2.Nature cell biology · 2023
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 1 country.

Deepak MenonFrom the Department of Biological Sciences, Hunter College of the City University of New York, New York, New York 10065.
Darin SalloumFrom the Department of Biological Sciences, Hunter College of the City University of New York, New York, New York 10065.
Elyssa BernfeldFrom the Department of Biological Sciences, Hunter College of the City University of New York, New York, New York 10065.
Elizabeth GorodetskyFrom the Department of Biological Sciences, Hunter College of the City University of New York, New York, New York 10065.
Alla AkselrodFrom the Department of Biological Sciences, Hunter College of the City University of New York, New York, New York 10065.
Maria A FriasFrom the Department of Biological Sciences, Hunter College of the City University of New York, New York, New York 10065.
Jessica Sudderththe Children's Medical Center Research Institute, University of Texas Southwestern Medical Center, Dallas, Texas 75390, and.
Pei-Hsuan Chenthe Children's Medical Center Research Institute, University of Texas Southwestern Medical Center, Dallas, Texas 75390, and.
Ralph DeBerardinisthe Children's Medical Center Research Institute, University of Texas Southwestern Medical Center, Dallas, Texas 75390, and.
David A FosterFrom the Department of Biological Sciences, Hunter College of the City University of New York, New York, New York 10065, foster@genectr.hunter.cuny.edu.
The Graduate Center, CUNY · USChildren's Medical Center · USHunter College · USCity University of New York · USCornell University · USThe University of Texas Southwestern Medical Center · US

Funding

Role of phospholipase D in tumorigenesisR01CA046677 · NCI · HUNTER COLLEGE · PI FOSTER, DAVID A · 1997 to 2014
$3.6M
Dysregulated Metabolic Cell Cycle Checkpoints in Human CancerR01CA179542 · NCI · HUNTER COLLEGE · PI FOSTER, DAVID A · 2014 to 2018
$1.3M
NCI NIH HHS R01 CA046677NCI NIH HHS R01 CA179542
6 · The paper itself

Abstract

mTOR, the mammalian target of rapamycin, integrates growth factor and nutrient signals to promote a transformation from catabolic to anabolic metabolism, cell growth, and cell cycle progression. Phosphatidic acid (PA) interacts with the FK506-binding protein-12-rapamycin-binding (FRB) domain of mTOR, which stabilizes both mTOR complexes: mTORC1 and mTORC2. We report here that mTORC1 and mTORC2 are activated in response to exogenously supplied fatty acids via the

Indexed as

FemaleG1 Phase Cell Cycle CheckpointsHep G2 CellsHumansMaleMCF-7 CellsMechanistic Target of Rapamycin Complex 1Mechanistic Target of Rapamycin Complex 2Multiprotein ComplexesOleic AcidPhosphatidic AcidsProto-Oncogene Proteins p21(ras)TOR Serine-Threonine KinasesKRAS protein, humanMechanistic Target of Rapamycin Complex 1Mechanistic Target of Rapamycin Complex 2MTOR protein, humanMultiprotein ComplexesOleic AcidPhosphatidic AcidsProto-Oncogene Proteins p21(ras)TOR Serine-Threonine Kinasesglycolysislipidmammalian target of rapamycin (mTOR)phosphatidic acidphospholipase DRas protein

Identifiers

PMID28223357
PMCPMC5391759
OpenAlexW2589276620

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.